ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
69,060.99
-0.30%
S&P 500
5,304.72
0.70%
Dow Jones
39,069.59
0.01%
US Dollar vs Yen
156.955
0.00%
Brent Oil
81.965
0.00%
Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. Medicines Company (MDCO)

  7. Medicines Company (MDCO) ニュース

MDCO

Medicines (MDCO)

Medicines Company
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:MDCO
日付受信時刻ニュースソース見出しコード企業名
2020/02/1507 : 43Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:MDCOMedicines Company
2020/02/1221 : 51Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:MDCOMedicines Company
2020/02/1221 : 24Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:MDCOMedicines Company
2020/02/1021 : 35Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:MDCOMedicines Company
2020/01/2823 : 59Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:MDCOMedicines Company
2020/01/1700 : 07Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)NASDAQ:MDCOMedicines Company
2020/01/1020 : 01Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:MDCOMedicines Company
2020/01/1020 : 00Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:MDCOMedicines Company
2020/01/1020 : 00Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:MDCOMedicines Company
2020/01/0806 : 36Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:MDCOMedicines Company
2020/01/0722 : 39Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:MDCOMedicines Company
2020/01/0703 : 34Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:MDCOMedicines Company
2020/01/0703 : 33Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:MDCOMedicines Company
2020/01/0703 : 32Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:MDCOMedicines Company
2020/01/0703 : 31Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:MDCOMedicines Company
2020/01/0703 : 30Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:MDCOMedicines Company
2020/01/0703 : 29Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:MDCOMedicines Company
2020/01/0703 : 28Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:MDCOMedicines Company
2020/01/0703 : 28Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:MDCOMedicines Company
2020/01/0703 : 26Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:MDCOMedicines Company
2020/01/0703 : 25Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:MDCOMedicines Company
2020/01/0703 : 12Business WireThe Medicines Company Announces Effective Date Of Make-Whole Fundamental Change Relating To Its 2.50% Convertible Senior Note...NASDAQ:MDCOMedicines Company
2020/01/0702 : 51Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:MDCOMedicines Company
2020/01/0702 : 51Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:MDCOMedicines Company
2020/01/0702 : 51Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:MDCOMedicines Company
2020/01/0702 : 50Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:MDCOMedicines Company
2020/01/0702 : 50Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:MDCOMedicines Company
2020/01/0702 : 50Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:MDCOMedicines Company
2020/01/0702 : 49Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:MDCOMedicines Company
2020/01/0702 : 49Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:MDCOMedicines Company
 Showing the most relevant articles for your search:NASDAQ:MDCO

最近閲覧した銘柄

NASDAQ
GOOGL
Alphabet
NASDAQ
TSLA
Tesla
USOTC
BASFY
BASF (QX)
CCOM
US30
US 30
USOTC
RHHBY
Roche (QX)
NYSE
BAC
Bank of America
NYSE
MRK
Merck
FX
USDEUR
US Dollar vs Euro
CCOM
US100
US Tech 100
USOTC
ADDYY
Adidas (QX)
NYSE
AXP
American Express
SPI
SP500
S&P 500
AMEX
SPY
SPDR S&P 500
NYSE
DIS
Walt Disney
NASDAQ
AMZN
Amazon.com
AMEX
XLF
Financial Select Sector
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

日本
会社情報
ビジネス
人気
アプリを入手
App Store
Google Play

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有